390 related items for PubMed ID: 32810506
1. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
J Pediatr; 2020 Dec; 227():224-230.e3. PubMed ID: 32810506
[Abstract] [Full Text] [Related]
2. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
[Abstract] [Full Text] [Related]
3. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
J Pediatr; 2022 Jan 15; 240():158-163.e4. PubMed ID: 34461064
[Abstract] [Full Text] [Related]
4. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, Tremoulet AH.
Arch Dis Child; 2023 Oct 15; 108(10):833-838. PubMed ID: 37258054
[Abstract] [Full Text] [Related]
5. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Oct 15; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
6. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
Tanaka A, Inoue M, Hoshina T, Koga H.
J Pediatr; 2021 Sep 15; 236():95-100. PubMed ID: 34019881
[Abstract] [Full Text] [Related]
7. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores.
Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, Lo MS, Baker AL, Sundel RP, Newburger JW.
J Am Heart Assoc; 2017 May 31; 6(6):. PubMed ID: 28566299
[Abstract] [Full Text] [Related]
8. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 31; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
9. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
Edraki MR, Mohammadi H, Mehdizadegan N, Ghorashi M, Amoozgar H, Borzouee M, Ajami G, Keshavarz K, Dehghani E, Bahrami R.
Arch Iran Med; 2020 Jan 01; 23(1):31-36. PubMed ID: 31910632
[Abstract] [Full Text] [Related]
10. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.
JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955
[Abstract] [Full Text] [Related]
11. The Harada score in the US population of children with Kawasaki disease.
Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
Hosp Pediatr; 2014 Jul 07; 4(4):233-8. PubMed ID: 24986993
[Abstract] [Full Text] [Related]
12. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
Arch Dis Child; 2021 Mar 07; 106(3):247-252. PubMed ID: 32943389
[Abstract] [Full Text] [Related]
13. Predicting IVIG resistance in UK Kawasaki disease.
Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
Arch Dis Child; 2015 Apr 07; 100(4):366-8. PubMed ID: 25670405
[Abstract] [Full Text] [Related]
14. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
Suzuki T, Kakimoto N, Tsuchihashi T, Suenaga T, Takeuchi T, Shibuta S, Kitano N, Suzuki H.
Eur J Pediatr; 2021 Sep 07; 180(9):2797-2805. PubMed ID: 33763715
[Abstract] [Full Text] [Related]
15. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
Cardiology; 2023 Sep 07; 148(5):457-468. PubMed ID: 37231847
[Abstract] [Full Text] [Related]
16. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
Wang J, Chen H, Shi H, Zhang X, Shao Y, Hang B, Xu Z, Rong X, Chu M, Qiu H.
Pediatr Rheumatol Online J; 2020 Jun 11; 18(1):48. PubMed ID: 32527316
[Abstract] [Full Text] [Related]
17. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].
Liu WQ, Xia B, Fan W, Yu Z, Lin WL, Chen L, Wang C, Liu BN, Li J, Yang J.
Zhonghua Er Ke Za Zhi; 2022 Jun 02; 60(6):588-593. PubMed ID: 35658368
[Abstract] [Full Text] [Related]
18. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
[Abstract] [Full Text] [Related]
19. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 26; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
20. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H.
Clin Rheumatol; 2018 Jul 26; 37(7):1945-1951. PubMed ID: 29330741
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
